Literature DB >> 17442625

Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass.

Dana D Portenier1, John P Grant, Hilary S Blackwood, Aurora Pryor, Ross L McMahon, Eric DeMaria.   

Abstract

BACKGROUND: Because of the claim that about one third of patients develop gallstones within 6 months of Roux-en-Y gastric bypass (RYGB), many have recommended preoperative ultrasonography for all patients and/or prophylactic cholecystectomy (CCY), or ursodiol to prevent stone formation.
METHODS: Prospective data were collected from 1391 consecutive patients followed up for > or = 6 months after RYGB (2000-2005) to assess our practice of not routinely removing the gallbladder and not administering ursodiol.
RESULTS: Of the 1391 patients, 334 (24%) had undergone CCY before RYGB. Of the remaining 1057 asymptomatic patients, 516 had undergone preoperative ultrasonography. Stones were identified in 99 (19%), sludge in 5 (0.97%), and polyps in 6 (1.1%). Of the 984 patients with gallbladders left in situ after RYGB, only 80 (8.1%) became symptomatic and required delayed CCY. The average excess weight loss at the delayed CCY was 65%. The risk of undergoing delayed CCY seemed to be restricted to the first 29 months after RYGB, because none of 165 patients followed up for 30-144 months required CCY.
CONCLUSION: Although CCY should be performed whenever symptoms mandate, the value of routine preoperative ultrasonography and CCY was not apparent from the results of our study. Waiting until symptoms develop might simplify the operative procedure because of the significant weight loss that should have occurred after RYGB. Using an expectant approach, most patients undergoing RYGB will not require CCY.

Entities:  

Mesh:

Year:  2007        PMID: 17442625     DOI: 10.1016/j.soard.2007.02.006

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  25 in total

1.  Early changes in postprandial gallbladder emptying in morbidly obese patients undergoing Roux-en-Y gastric bypass: correlation with the occurrence of biliary sludge and gallstones.

Authors:  Michel Bastouly; Carlos Haruo Arasaki; Jael Brasil Ferreira; Arnaldo Zanoto; Fabíola Gouveia H P Borges; José Carlos Del Grande
Journal:  Obes Surg       Date:  2008-08-12       Impact factor: 4.129

2.  Prevalence of Cholelithiasis and Choledocholithiasis in Morbidly Obese South Indian Patients and the Further Development of Biliary Calculus Disease After Sleeve Gastrectomy, Gastric Bypass and Mini Gastric Bypass.

Authors:  Tapas Mishra; Kona Kumari Lakshmi; Kiran Kumar Peddi
Journal:  Obes Surg       Date:  2016-10       Impact factor: 4.129

3.  Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass?

Authors:  Mathieu D'Hondt; Gregory Sergeant; Bert Deylgat; Dirk Devriendt; Frank Van Rooy; Franky Vansteenkiste
Journal:  J Gastrointest Surg       Date:  2011-07-13       Impact factor: 3.452

4.  Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure? A comparative cohort study.

Authors:  Ignazio Tarantino; Renè Warschkow; Thomas Steffen; Philipp Bisang; Bernd Schultes; Martin Thurnheer
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129

5.  Concomitant cholecystectomy should be routinely performed with laparoscopic Roux-en-Y gastric bypass.

Authors:  Anna C Weiss; Tazo Inui; Ralitza Parina; Alisa M Coker; Garth Jacobsen; Santiago Horgan; Mark Talamini; David C Chang; Bryan Sandler
Journal:  Surg Endosc       Date:  2014-12-17       Impact factor: 4.584

Review 6.  Concomitant cholecystectomy during laparoscopic Roux-en-Y gastric bypass in obese patients is not justified: a meta-analysis.

Authors:  Rene Warschkow; Ignazio Tarantino; Kristjan Ukegjini; Ulrich Beutner; Ulrich Güller; Bruno M Schmied; Sascha A Müller; Bernd Schultes; Martin Thurnheer
Journal:  Obes Surg       Date:  2013-03       Impact factor: 4.129

Review 7.  Management of gallstones and gallbladder disease in patients undergoing gastric bypass.

Authors:  Bernabé M Quesada; Gustavo Kohan; Hernán E Roff; Carlos M Canullán; Luis T Chiappetta Porras
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

8.  Concomitant cholecystectomy during laparoscopic sleeve gastrectomy.

Authors:  Asnat Raziel; Nasser Sakran; Amir Szold; David Goitein
Journal:  Surg Endosc       Date:  2014-12-06       Impact factor: 4.584

9.  Risk of Biliary Events After Selective Cholecystectomy During Biliopancreatic Diversion with Duodenal Switch.

Authors:  Iswanto Sucandy; Moaz Abulfaraj; Mary Naglak; Gintaras Antanavicius
Journal:  Obes Surg       Date:  2016-03       Impact factor: 4.129

10.  Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy.

Authors:  Vicky Ka Ming Li; Nestor Pulido; Patricio Fajnwaks; Samuel Szomstein; Raul Rosenthal; Pedro Martinez-Duartez
Journal:  Surg Endosc       Date:  2008-12-05       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.